Molecular and Structural Imaging in Atypical Alzheimer's Disease: A Longitudinal Study
Status:
Recruiting
Trial end date:
2026-03-01
Target enrollment:
Participant gender:
Summary
This is a neuroimaging study designed to learn more about amyloid and tau burden in the brain
of patients with Atypical Alzheimer's Disease and how burden may change over a one year
period.